Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Andexanet Alfa and 4F-PCC Use in Patients Hospitalised With an Anticoagulant-related Major Bleed

NCT05548777 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05548777
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05548777 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Andexanet Alfa and 4F-PCC Use in Patients Hospitalised With an Anticoagulant-related Major Bleed
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
September 15, 2022
Completion date
December 20, 2022
Enrollment
5,480 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulant-related major bleed